Does SATRALIZUMAB Cause Urinary tract infection? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Urinary tract infection have been filed in association with SATRALIZUMAB (Enspryng). This represents 9.6% of all adverse event reports for SATRALIZUMAB.
21
Reports of Urinary tract infection with SATRALIZUMAB
9.6%
of all SATRALIZUMAB reports
4
Deaths
17
Hospitalizations
How Dangerous Is Urinary tract infection From SATRALIZUMAB?
Of the 21 reports, 4 (19.0%) resulted in death, 17 (81.0%) required hospitalization, and 1 (4.8%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SATRALIZUMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does SATRALIZUMAB Cause?
Neuromyelitis optica spectrum disorder (46)
Off label use (26)
Muscular weakness (19)
Optic neuritis (15)
Hypoaesthesia (14)
Infection (14)
Pneumonia (13)
Covid-19 (11)
Fatigue (11)
Pain (11)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which SATRALIZUMAB Alternatives Have Lower Urinary tract infection Risk?
SATRALIZUMAB vs SATRALIZUMAB-MWGE
SATRALIZUMAB vs SAXAGLIPTIN
SATRALIZUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SATRALIZUMAB vs SCOPOLAMINE
SATRALIZUMAB vs SCOPOLAMINE HYDROBROMIDE